Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics

See also
Status	Clinical Trial	Phase
Completed	`NCT00792623` - Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).	Phase 2
Enrolling by invitation	`NCT05015686` - Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old	Phase 3
Completed	`NCT00092430` - Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)	Phase 3
Completed	`NCT00384397` - A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers	Phase 3
Completed	`NCT00226499` - Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox	Phase 3
Completed	`NCT00402831` - ProQuad® Intramuscular vs Subcutaneous	Phase 3
Not yet recruiting	`NCT06068608` - A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy	Phase 1
Completed	`NCT00560755` - Safety Study of ProQuad® rHA in Infants (V221-037)	Phase 3
Completed	`NCT00715234` - Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients	N/A
Terminated	`NCT00258726` - Immune Responses to Two Dose Varivax +/- MMR-II	Phase 1/Phase 2
Completed	`NCT03239873` - Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)	Phase 3
Completed	`NCT00751348` - Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136	Phase 3
Completed	`NCT00969436` - Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM	Phase 3
Completed	`NCT00566527` - Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)	Phase 3
Completed	`NCT00127010` - Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases	Phase 3
Completed	`NCT00578175` - Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age	Phase 2
Completed	`NCT00568334` - Study of Two Formulations of GSK Biologicals' Varicella Vaccine	Phase 2
Completed	`NCT03114982` - The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age	Phase 2
Completed	`NCT00483574` - Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers	Phase 3
Completed	`NCT00127023` - Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases	Phase 3

NCT number	NCT01390857
Study type	Observational
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	N/A
Start date	November 2007
Completion date	May 2010

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms